A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
This study has been completed.
Study NCT00490971
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on June 18, 2007.
Last Updated on October 27, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
